ACLARIS THERAPEUTICS INC shareholders Q3 2023

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

ACLARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PROFUND ADVISORS LLC 13,098$89,7210.01%
Citadel Advisors 3,357,240$22,997,0940.01%
China Universal Asset Management Co., Ltd. 1,814$12,4260.00%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 63,320$4340.00%
TWO SIGMA ADVISERS, LP 146,000$1,000,1000.00%
J. Goldman & Co LP 11,456$78,4740.00%
ALPS ADVISORS INC 52,222$357,7210.00%
Point72 Middle East FZE 10,692$73,2400.00%
STRS OHIO 54,100$3700.00%
VIRGINIA RETIREMENT SYSTEMS ET Al 27,200$186,3200.00%
Man Group plc 93,386$639,6940.00%
Leucadia National 36,551$250,3740.00%
MetLife Investment Management, LLC 35,160$240,8460.00%
Cubist Systematic Strategies, LLC 43,024$294,7140.00%
Walleye Capital LLC 115,962$794,3400.00%
Ameritas Investment Partners, Inc. 6,900$47,2650.00%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 70,000$117,0000.00%
Leucadia National 25,300$173,3050.00%
HSBC HOLDINGS PLC 246,587$1,669,3940.00%
AMERICAN INTERNATIONAL GROUP, INC. 34,661$237,4280.00%
External links

This page lists ACLARIS THERAPEUTICS INC's shareholders in Q3 2023. To view ACLARIS THERAPEUTICS INC's shareholder history, click here.